These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
207 related articles for article (PubMed ID: 30854720)
21. The serum levels of activin A and bone morphogenetic protein-4 and -6 in patients with fibrodysplasia ossificans progressiva. Ye Z; Wang S; Shan C; Zhu Q; Xue Y; Zhang K Orphanet J Rare Dis; 2023 May; 18(1):111. PubMed ID: 37165433 [TBL] [Abstract][Full Text] [Related]
22. ACVR1-Fc suppresses BMP signaling and chondro-osseous differentiation in an in vitro model of Fibrodysplasia ossificans progressiva. Pang J; Zuo Y; Chen Y; Song L; Zhu Q; Yu J; Shan C; Cai Z; Hao J; Kaplan FS; Shore EM; Zhang K Bone; 2016 Nov; 92():29-36. PubMed ID: 27492611 [TBL] [Abstract][Full Text] [Related]
23. Variable signaling activity by FOP ACVR1 mutations. Haupt J; Xu M; Shore EM Bone; 2018 Apr; 109():232-240. PubMed ID: 29097342 [TBL] [Abstract][Full Text] [Related]
24. Molecular Developmental Biology of Fibrodysplasia Ossificans Progressiva: Measuring the Giant by Its Toe. Towler OW; Shore EM; Kaplan FS Biomolecules; 2024 Aug; 14(8):. PubMed ID: 39199396 [TBL] [Abstract][Full Text] [Related]
25. ACVR1 (587T>C) mutation in a variant form of fibrodysplasia ossificans progressiva: second report. Nakahara Y; Katagiri T; Ogata N; Haga N Am J Med Genet A; 2014 Jan; 164A(1):220-4. PubMed ID: 24259422 [TBL] [Abstract][Full Text] [Related]
26. Variant BMP receptor mutations causing fibrodysplasia ossificans progressiva (FOP) in humans show BMP ligand-independent receptor activation in zebrafish. Mucha BE; Hashiguchi M; Zinski J; Shore EM; Mullins MC Bone; 2018 Apr; 109():225-231. PubMed ID: 29307777 [TBL] [Abstract][Full Text] [Related]
27. Nonclassic fibrodysplasia ossificans progressiva: A child from Angola with an ACVR1 Martín-García D; Towler OW; Xu M; Alfonso-Hernández O; Oliveira PR; Alonso-Clavo M; Shore EM; Kaplan FS Am J Med Genet A; 2021 Aug; 185(8):2572-2575. PubMed ID: 33973349 [TBL] [Abstract][Full Text] [Related]
28. Fibrodysplasia ossificans progressiva (FOP): A disorder of osteochondrogenesis. Kaplan FS; Al Mukaddam M; Stanley A; Towler OW; Shore EM Bone; 2020 Nov; 140():115539. PubMed ID: 32730934 [TBL] [Abstract][Full Text] [Related]
29. Twists in the fibrodysplasia ossificans progressiva story challenge and expand our understanding of BMP biology. Collins MT J Clin Invest; 2022 Jun; 132(12):. PubMed ID: 35703179 [TBL] [Abstract][Full Text] [Related]
32. Fibrodysplasia ossificans progressiva (FOP): watch the great toes! Kartal-Kaess M; Shore EM; Xu M; Schwering L; Uhl M; Korinthenberg R; Niemeyer C; Kaplan FS; Lauten M Eur J Pediatr; 2010 Nov; 169(11):1417-21. PubMed ID: 20577760 [TBL] [Abstract][Full Text] [Related]
33. How Activin A Became a Therapeutic Target in Fibrodysplasia Ossificans Progressiva. Srinivasan D; Arostegui M; Goebel EJ; Hart KN; Aykul S; Lees-Shepard JB; Idone V; Hatsell SJ; Economides AN Biomolecules; 2024 Jan; 14(1):. PubMed ID: 38254701 [TBL] [Abstract][Full Text] [Related]
34. Functional comparison of human ACVR1 and zebrafish Acvr1l FOP-associated variants in embryonic zebrafish. Lalonde RL; Nicolas HA; Cutler RS; Pantekidis I; Zhang W; Yelick PC Dev Dyn; 2023 May; 252(5):605-628. PubMed ID: 36606464 [TBL] [Abstract][Full Text] [Related]
35. Rarely occurring mutation of ACVR1 gene in Moroccan patient with fibrodysplasia ossificans progressiva. Ratbi I; Bocciardi R; Regragui A; Ravazzolo R; Sefiani A Clin Rheumatol; 2010 Jan; 29(1):119-21. PubMed ID: 19795179 [TBL] [Abstract][Full Text] [Related]
36. An ACVR1 Kaplan FS; Groppe JC; Xu M; Towler OW; Grunvald E; Kalunian K; Kallish S; Al Mukaddam M; Pignolo RJ; Shore EM Am J Med Genet A; 2022 Mar; 188(3):806-817. PubMed ID: 34854557 [TBL] [Abstract][Full Text] [Related]
37. Classical and atypical Fibrodysplasia Ossificans Progressiva in India. Madhuri V; Santhanam M; Sugumar LK; Rajagopal K; Chilbule SK Ann Hum Genet; 2015 Jul; 79(4):245-52. PubMed ID: 26058333 [TBL] [Abstract][Full Text] [Related]
38. The Developmental Phenotype of the Great Toe in Fibrodysplasia Ossificans Progressiva. Towler OW; Kaplan FS; Shore EM Front Cell Dev Biol; 2020; 8():612853. PubMed ID: 33364240 [TBL] [Abstract][Full Text] [Related]
39. Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop. Aykul S; Corpina RA; Goebel EJ; Cunanan CJ; Dimitriou A; Kim HJ; Zhang Q; Rafique A; Leidich R; Wang X; McClain J; Jimenez J; Nannuru KC; Rothman NJ; Lees-Shepard JB; Martinez-Hackert E; Murphy AJ; Thompson TB; Economides AN; Idone V Elife; 2020 Jun; 9():. PubMed ID: 32515349 [TBL] [Abstract][Full Text] [Related]
40. Multi-system involvement in a severe variant of fibrodysplasia ossificans progressiva (ACVR1 c.772G>A; R258G): A report of two patients. Kaplan FS; Kobori JA; Orellana C; Calvo I; Rosello M; Martinez F; Lopez B; Xu M; Pignolo RJ; Shore EM; Groppe JC Am J Med Genet A; 2015 Oct; 167A(10):2265-71. PubMed ID: 26097044 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]